AI in Precision Drug Discovery: How the $6M Model That Beat a $100M Drug Is Rewriting Pharma in 2026
AI-designed drugs hit Phase IIa, compress timelines from 12 to 3 years, and invert pharma economics. Here is how it works and what it means.
The Magicx journal · topic
2 articles to explore, from first steps to what comes next.
AI-designed drugs hit Phase IIa, compress timelines from 12 to 3 years, and invert pharma economics. Here is how it works and what it means.
AI-driven drug discovery is slashing traditional pharma timelines by 80%. With multiple AI-discovered drugs now in Phase II trials, the biotech investment landscape is being rewritten.